Evolent Health shared its third-quarter results, showing $725 million in sales, an 11% rise from last quarter.

Nov 5, 2026, 9:30 AM ETResultsRead the original at Benzinga

Good for EVH

EVH grew Q3 revenue and adjusted EBITDA, and raised its full-year adjusted EBITDA forecast. Its revenue forecast stayed the same, but customer renewals and expansions add support.

EVH · Evolent Health

AI read · Good for EVH

The AI's read

This suggests Evolent is bringing in more sales and producing more operating profit. Customer renewals and expansions also show clients are keeping or adding its services. The sales forecast stayed the same, and expected savings from AI have not happened yet.

Get alerts for EVH

Follow Evolent Health (EVH) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for EVH

Free on the App Store and Google Play, or on the web.